Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Androgenetic alopecia in males is linked to hormone levels and the enzyme 5-alpha reductase.

Adrenarche increases adrenal androgens around age 6, affecting hair growth and development.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

PSA can help diagnose high androgen levels in women.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Understanding hormones is key to treating certain skin conditions.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

5α-reductase-2 deficiency causes ambiguous genitalia at birth and affects male sexual development, but individuals often develop male characteristics at puberty.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Postmenopausal hyperandrogenism involves excess male hormones causing symptoms like hair growth and acne, and requires ruling out tumors and other disorders.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.